Standard BioTools Inc. (LAB)
NASDAQ: LAB · Real-Time Price · USD
1.510
-0.050 (-3.21%)
At close: Jan 20, 2026, 4:00 PM EST
1.520
+0.010 (0.66%)
After-hours: Jan 20, 2026, 6:09 PM EST
Standard BioTools Employees
As of December 31, 2024, Standard BioTools had 818 total employees, including 814 full-time and 4 part-time employees. The number of employees increased by 279 or 51.76% compared to the previous year.
Employees
818
Change (1Y)
279
Growth (1Y)
51.76%
Revenue / Employee
$207,502
Profits / Employee
-$156,786
Market Cap
580.69M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 818 | 279 | 51.76% | 814 | 4 |
| Dec 31, 2023 | 539 | 16 | 3.06% | 534 | 5 |
| Dec 31, 2022 | 523 | -92 | -14.96% | 523 | 0 |
| Dec 31, 2021 | 615 | -12 | -1.91% | 615 | 0 |
| Dec 31, 2020 | 627 | 61 | 10.78% | 627 | 0 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
LAB News
- 12 days ago - Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2025 Revenue - GlobeNewsWire
- 2 months ago - Molecular Instruments and Standard BioTools Announce Collaboration to Bring Amplified Multi-Omic Readouts to Imaging Mass Cytometry - Business Wire
- 2 months ago - Illumina® Protein Prep delivers groundbreaking precision in NGS proteomics for more than 40 customers, ranging from academic institutions to large national biobanks - PRNewsWire
- 2 months ago - Standard BioTools Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 3 months ago - Standard BioTools to Announce Third Quarter Financial Results on November 4, 2025 - GlobeNewsWire
- 4 months ago - Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development - PRNewsWire
- 5 months ago - Standard BioTools Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 5 months ago - Standard BioTools and Precision Health Research, Singapore (PRECISE-SG100K) Launch Proteomics Collaboration, Selecting SomaScan to Power Large-Scale Population Health Study - GlobeNewsWire